30-Jul-2010 | S | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2010, inter alia, has transacted the following:
The Board has considered and approved the consolidation of shares from Existing Re. 1/- paid up to Rs. 10/- paid-up subject to approval of shareholders.
Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on August 30, 2010, inter alia, have passed the following resolutions:
Approved the Consolidation of Capital from existing Equity share of Re. 1/- to Equity Share of Rs. 10/-.
(As Per BSE Announcement Website dated on 30.08.2010)
SUB. : - Consolidation of equity shares of Trimurthi Drugs & Pharmaceuticals Limited (Scrip Code 590093)
Trading members of the Exchange are hereby informed that, Trimurthi Drugs & Pharmaceuticals Limited has fixed the Record Date for the purpose of Consolidation of the equity shares of the company. Trading members of the Exchange are hereby advised not to deal in the Equity Shares of the Company as mentioned here under.
COMPANY NAME CODE
Trimurthi Drugs & Pharmaceuticals Limited
(590093)
RECORD DATE
05/10/2010
PURPOSE
Consolidation of existing TEN equity shares from Re.1/- each to ONE equity share of Rs.10/- each.
NO DEALINGS FROM
04/10/2010 DR-132/2010-2011
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 17.09.2010) | 05-Oct-2010 | |
25-Jul-2009 | S | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2009, inter alia, has transacted the following:
Board of directors discussed and considered the subdivision of the each Equity Share of Rs 10/- each into 10 equity shares of Rs 1/- each subject to the approval of Shareholders in ensuing AGM.
Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the members at the 15th Annual General Meeting (AGM) of the Company held on September 07, 2009, inter alia, have accorded to the following:
Approved split of Equity shares from 1 equity share of Rs 10/- each to 10 equity shares of Rs 1/- per share.
(As Per BSE Announcement Dated on 08/09/2009)
Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that October 16, 2009 has been fixed as the Record for the purpose of subdivision of the each Equity Share of Rs. 10/- each into 10 equity shares of Rs. 1/- each.
(As Per BSE Announcement Website dated on 18.09.2009)
SUB. :- Sub Division of equity shares of Trimurthi Drugs & Pharmaceuticals Limited (Scrip Code 590093)
Trading Members of the Exchange are hereby informed that, Trimurthi Drugs & Pharmaceuticals Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Trimurthi Drugs & Pharmaceuticals Limited
(590093)
RECORD DATE
16/10/2009
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
15/10/2009 DR- 135/2009- 2010
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 15/10/2009.
ii. ISIN No. INE314I01010 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 15/10/2009.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice
(As Per BSE Notice Dated on 05.10.2009) | 16-Oct-2009 | |
23-Jul-2012 | D | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 21, 2012, inter alia, has transacted the following:
The Board after detailed discussion has recommended the dividend of 3% on the equity shares for the year 2011-12. | 16-Aug-2012 | |
22-Aug-2011 | D | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 19, 2011, inter alia, have recommended the dividend of 3% on the equity shares for the year 2010-11. | 22-Sep-2011 | |
28-Jul-2010 | D | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 23, 2010, inter alia, has recommended the dividend of 3% (Rs. 0.03) on the equity shares for the year 2009-10. | 23-Aug-2010 | |
25-Jul-2009 | D | Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2009, inter alia, has transacted the following:
The Board has recommended the dividend of 3% on the equity shares for the year 2008-09. | 01-Sep-2009 | |
05-Mar-2024 | BC | Mark Corporate Advisors Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of Public Announcement under Regulation 3(1) and 4 read with Regulation 13(2)(g) And 15(1) of Securities and Excha | 06-May-2024 | |
05-Mar-2024 | BC | 2. Draft Postal Ballot Notice Approved 3. Mr. Artham Someswara Rao, (ACS: 18979 CP No.: 19530) of M/s A. Someswara Rao & Associates, Practicing Company Secretary, Hyderabad, is appointed as the Scrut | 05-Apr-2024 | |
29-Feb-2024 | BC | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/03/2024 inter alia to consider and approve To discuss/ finalize the proposal for Issue of Eq | 05-Mar-2024 | |
22-Jan-2024 | BC | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve un-audited financial results for the quarter ende | 30-Jan-2024 | |
08-Dec-2023 | BC | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 inter alia to consider and approve Results
Outcome of board meeting held on 15.12 | 15-Dec-2023 | |
Announcement Date23-Jul-2012
Ex Dividend Date16-Aug-2012
Dividend(%)3
Announcement Date22-Aug-2011
Ex Dividend Date22-Sep-2011
Dividend(%)3
Announcement Date28-Jul-2010
Ex Dividend Date23-Aug-2010
Dividend(%)3
Announcement Date25-Jul-2009
Ex Dividend Date01-Sep-2009
Dividend(%)3
No Bonus has been declared by Trimurthi
Record Date05-Oct-2010
Split Date04-Oct-2010
Face Value (Before/After)1/10
Record Date16-Oct-2009
Split Date15-Oct-2009
Face Value (Before/After)10/1
RightsNo Rights has been declared by Trimurthi
Book Closure
06-May-2024 | 01 Jan'1900 | Mark Corporate Advisors Pvt Ltd ('Manager to the Offer') has submitted to BSE a copy of Public Announcement under Regulation 3(1) and 4 read with Regulation 13(2)(g) And 15(1) of Securities and Excha |
05-Apr-2024 | 01 Jan'1900 | 2. Draft Postal Ballot Notice Approved 3. Mr. Artham Someswara Rao, (ACS: 18979 CP No.: 19530) of M/s A. Someswara Rao & Associates, Practicing Company Secretary, Hyderabad, is appointed as the Scrut |
05-Mar-2024 | - | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/03/2024 inter alia to consider and approve To discuss/ finalize the proposal for Issue of Eq |
30-Jan-2024 | - | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve un-audited financial results for the quarter ende |
15-Dec-2023 | - | Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 inter alia to consider and approve Results
Outcome of board meeting held on 15.12 |